Tg Therapeutics Stock In The News
| TGTX Stock | USD 13.98 0.27 1.89% |
The overall news coverage of TG Therapeutics from major news outlets shows solid bullish sentiment on 8 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of TG Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards TG Therapeutics. The specific impact of TG Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of TG Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using TG Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out TG Therapeutics Backtesting and TG Therapeutics Hype Analysis. For more information on how to buy TGTX Stock please use our How to Invest in TG Therapeutics guide.
TGTX |
TG Therapeutics Today Top News and Investor Outlook
TG Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide TGTX and other traded companies coverage. We help investors stay connected with TGTX headlines for the 24th of April to make an informed investment decision based on correlating the impacts of news items on TGTX Stock performance. Please note that trading solely based on the TG Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.TG Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the TGTX earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about TG Therapeutics that are available to investors today. That information is available publicly through TGTX media outlets and privately through word of mouth or via TGTX internal channels. However, regardless of the origin, that massive amount of TGTX data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of TG Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of TG Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to TG Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive TG Therapeutics alpha.
TGTX Largest EPS Surprises
Earnings surprises can significantly impact TG Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2014-03-05 | 2013-12-31 | -0.17 | -0.19 | -0.02 | 11 | ||
2013-05-14 | 2013-03-31 | -0.15 | -0.17 | -0.02 | 13 | ||
2012-11-08 | 2012-09-30 | -0.12 | -0.16 | -0.04 | 33 | ||
2017-11-08 | 2017-09-30 | -0.43 | -0.48 | -0.05 | 11 | ||
2016-08-08 | 2016-06-30 | -0.28 | -0.33 | -0.05 | 17 | ||
2016-03-07 | 2015-12-31 | -0.32 | -0.37 | -0.05 | 15 |
TG Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to TG Therapeutics Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.
18th of April 2024
TG Therapeutics Announces Additional Data Presentations for BRIUMVI in Multiple Sclerosis ... at finance.yahoo.com
15th of April 2024
TG Therapeutics highlights BRIUMVI data at AAN meeting at investing.com
4th of April 2024
Vanguard Group Inc. Has 112.62 Million Stock Position in TG Therapeutics, Inc. - Defense W... at news.google.com
25th of March 2024
TG Therapeutics Has A Somewhat Strained Balance Sheet at simplywall.st
20th of March 2024
TG Therapeutics, Inc. Receives Consensus Recommendation of Moderate Buy from Analysts - Ma... at news.google.com
14th of March 2024
Acquisition by Sean Power of 75000 shares of TG Therapeutics subject to Rule 16b-3 at MacroaxisInsider
12th of March 2024
Disposition of 22000 shares by Laurence Charney of TG Therapeutics at 15.97 subject to Rul... at MacroaxisInsider
8th of March 2024
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI in Multiple Sclerosis... at benzinga.com
28th of February 2024
TG Therapeutics Inc Announces Fourth Quarter and Full Year 2023 Financial Results at gurufocus.com
15th of February 2024
Bio-Rad Laboratories Surpasses Q4 Earnings Estimates at zacks.com
TG Therapeutics Investors Sentiment
The influence of TG Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in TGTX. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to TG Therapeutics' public news can be used to forecast risks associated with an investment in TGTX. The trend in average sentiment can be used to explain how an investor holding TGTX can time the market purely based on public headlines and social activities around TG Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
TG Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for TG Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average TG Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on TG Therapeutics.
TG Therapeutics Implied Volatility | 88.91 |
TG Therapeutics' implied volatility exposes the market's sentiment of TG Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if TG Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that TG Therapeutics stock will not fluctuate a lot when TG Therapeutics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards TG Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, TG Therapeutics' short interest history, or implied volatility extrapolated from TG Therapeutics options trading.
Check out TG Therapeutics Backtesting and TG Therapeutics Hype Analysis. For more information on how to buy TGTX Stock please use our How to Invest in TG Therapeutics guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for TGTX Stock analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is TG Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TG Therapeutics. If investors know TGTX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TG Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.09 | Revenue Per Share 1.646 | Quarterly Revenue Growth 548.638 | Return On Assets 0.0493 | Return On Equity 0.1157 |
The market value of TG Therapeutics is measured differently than its book value, which is the value of TGTX that is recorded on the company's balance sheet. Investors also form their own opinion of TG Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is TG Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TG Therapeutics' market value can be influenced by many factors that don't directly affect TG Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TG Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if TG Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TG Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.